These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 25270209)
1. [Regulatory effect of ginsenoside Rh2 on HDAC1/2 activity and cyclin in human erythroleukemia K562 cells]. Xia J; Chen D; Zuo G; Wei Q; You Z; Li D; Liu Z; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1062-6. PubMed ID: 25270209 [TBL] [Abstract][Full Text] [Related]
2. [Ginsenoside Rh2 inhibits proliferation and promotes apoptosis of leukemia KG1-α cells]. You Z; Chen D; Wei Q; Zhao L; Xia J; Li D; Li J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):565-8. PubMed ID: 24909273 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells. Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938 [TBL] [Abstract][Full Text] [Related]
4. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721]. Zeng XL; Tu ZG Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555 [TBL] [Abstract][Full Text] [Related]
5. [Effects of ginsenoside Rh2(GS-Rh2) on cell cycle of Eca-109 esophageal carcinoma cell line]. Li L; Qi FY; Liu JR; Zuo LF Zhongguo Zhong Yao Za Zhi; 2005 Oct; 30(20):1617-21. PubMed ID: 16422547 [TBL] [Abstract][Full Text] [Related]
6. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells]. Zhang C; Yu H; Hou J Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558 [TBL] [Abstract][Full Text] [Related]
7. 20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/β-catenin signaling pathway. Chen Y; Liu ZH; Xia J; Li XP; Li KQ; Xiong W; Li J; Chen DL Oncol Rep; 2016 Jul; 36(1):137-46. PubMed ID: 27121661 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression. Chung KS; Cho SH; Shin JS; Kim DH; Choi JH; Choi SY; Rhee YK; Hong HD; Lee KT Carcinogenesis; 2013 Feb; 34(2):331-40. PubMed ID: 23125221 [TBL] [Abstract][Full Text] [Related]
9. Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. Tang XP; Tang GD; Fang CY; Liang ZH; Zhang LY World J Gastroenterol; 2013 Mar; 19(10):1582-92. PubMed ID: 23538603 [TBL] [Abstract][Full Text] [Related]
10. [Ginsenoside Rh₂-induced inhibition of histone deacetylase 6 promotes K562 cells autophagy and apoptosis in vivo]. Liu ZH; Chen DL; Jiang R; Chen Y; Xiong W; Wang F; Shi XP; Li HX; Li J Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):700-704. PubMed ID: 28871696 [TBL] [Abstract][Full Text] [Related]
11. Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice. Wang Y; Ye F; Ke Q; Wu Q; Yang R; Bu H Transplant Proc; 2013 Mar; 45(2):463-73. PubMed ID: 23498780 [TBL] [Abstract][Full Text] [Related]
12. Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3β and degrading β-catenin. Shi Q; Shi X; Zuo G; Xiong W; Li H; Guo P; Wang F; Chen Y; Li J; Chen DL Oncol Rep; 2016 Oct; 36(4):2059-70. PubMed ID: 27573179 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458 [TBL] [Abstract][Full Text] [Related]
14. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Park WH; Kim ES; Kim BK; Lee YY Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794 [TBL] [Abstract][Full Text] [Related]
16. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins. Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270 [TBL] [Abstract][Full Text] [Related]
17. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest. Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006 [TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
19. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene]. Shen WJ; Dai DQ; Teng Y; Liu J Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115 [TBL] [Abstract][Full Text] [Related]
20. Effect of downregulated histone deacetylase 2 expression on cell proliferation and cell cycle in cervical cancer. Hua F; Sun J; Guo F; Yin S; Zhang Q; Zhang W; Liang W J BUON; 2014; 19(2):497-501. PubMed ID: 24965412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]